Chembio Diagnostics, Inc.
CEMIDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001092662
Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 30
- Q1 2023, −7 vs. previous quarter
- 13F value
- $1.36M
- Reported value at the end of Q1 2023
- Superinvestors holding
- 0
- At the end of Q1 2023
Superinvestors holding CEMI, Q1 2023
No superinvestor reported holding CEMI at the end of Q1 2023.
Latest insider trades
Open-market purchases and sales by Chembio Diagnostics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 (view filing)8:02 PM ET | Apr 21-25 | 4 days | Edelman Joseph and 2 others10% Owner | PPurchase | +243.4K | $0.4494 | +$109.4K | +4.9%5.16M after | 3 lots |
| Apr 20, 2023 (view filing)7:43 PM ET | Apr 18-20 | 2 days | Edelman Joseph and 2 others10% Owner | PPurchase | +208.8K | $0.4485 | +$93.7K | +4.4%4.92M after | 3 lots |
| Apr 17, 2023 (view filing)8:47 PM ET | Apr 13-17 | 4 days | Edelman Joseph and 2 others10% Owner | PPurchase | +156.4K | $0.45 | +$70.4K | +3.4%4.71M after | 3 lots |
| Apr 13, 2023 (view filing)4:35 PM ET | Apr 11 | 2 days | Edelman Joseph and 2 others10% Owner | PPurchase | +129.0K | $0.44 | +$56.8K | +2.9%4.55M after | |
| Apr 6, 2023 (view filing)9:37 PM ET | Apr 4-6 | 2 days | Edelman Joseph and 2 others10% Owner | PPurchase | +752.4K | $0.4429 | +$333.2K | +20.5%4.43M after | 3 lots |
Top 10 13F holders, Q1 2023
The largest institutional positions in Chembio Diagnostics, Inc. at the end of Q1 2023; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,561,470 | $690.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 279,456 | $123.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 206,051 | $91.1K | 0.00% | −193−0.1% | Reduced |
| PenderFund Capital Management Ltd. | 147,459 | $88.0K | 0.03% | +147,459 | New |
| Renaissance Technologies LLC | 157,100 | $69.0K | 0.00% | +20,700+15.2% | Added |
| Virtu Financial LLC | 143,265 | $63.0K | 0.01% | +62,646+77.7% | Added |
| Bank of New York Mellon Corp | 123,045 | $54.4K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 96,434 | $42.0K | 0.00% | +96,434 | New |
| Northern Trust Corp | 81,124 | $35.9K | 0.00% | −1,019−1.2% | Reduced |
| Signaturefd, LLC | 64,700 | $28.6K | 0.00% | +4,700+7.8% | Added |
Congress trades
1 member of Congress reported 1 trade in Chembio Diagnostics, Inc. since 2020. Newest filings:
| Filed | Member | Type | Amount |
|---|---|---|---|
| Aug 26, 2021 | Tom MalinowskiDemocrat · House · NJ | Sell | $1K-$15K |
Democrat · House · NJ · Aug 26, 2021
Sell$1K-$15K